Literature DB >> 27144298

Integrating Early Intervention for Borderline Personality Disorder and Mood Disorders.

Andrew M Chanen1, Michael Berk, Katherine Thompson.   

Abstract

Borderline personality disorder (BPD) has been demonstrated to be a reliable and valid construct in young people (adolescents and young adults). Both borderline- and mood-related psychopathology become clinically apparent from puberty through to young adulthood, frequently co-occur, can reinforce one another, and can be difficult to differentiate clinically. This Gordian knot of overlapping clinical features, common risk factors, and precursors to both BPD and mood disorders complicates clinical assessment, prevention, and treatment. Regardless of whether an individual crosses an arbitrary diagnostic threshold, a considerable proportion of young people with borderline- and mood-related psychopathology will develop significant and persistent functional, vocational, and interpersonal impairment and disability during this critical risk and developmental period. There is a clear need for early intervention, but spurious diagnostic certainty risks stigma, misapplication of diagnostic labels, inappropriate treatment, and unfavorable outcomes. This article aims to integrate early intervention for BPD and mood disorders in the clinical context of developmental and phenomenological change and evolution. "Clinical staging," similar to disease staging in general medicine, is presented as a pragmatic, heuristic, and trans-diagnostic framework to guide prevention and intervention. It acknowledges that the early stages of these disorders cannot be disentangled sufficiently to allow for disorder-specific preventive measures and early interventions. Clinical staging defines an individual's location along the continuum of the evolving temporal course of a disorder. Such staging aids differentiation of early or milder clinical phenomena from those that accompany illness progression and chronicity, and suggests the application of appropriate and proportionate intervention strategies.

Entities:  

Mesh:

Year:  2016        PMID: 27144298     DOI: 10.1097/HRP.0000000000000105

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  14 in total

1.  Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial.

Authors:  Mie Sedoc Jørgensen; Ole Jakob Storebø; Sune Bo; Stig Poulsen; Matthias Gondan; Emma Beck; Andrew M Chanen; Anthony Bateman; Jesper Pedersen; Erik Simonsen
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-05-09       Impact factor: 4.785

Review 2.  Diagnosis and Treatment of Borderline Personality Disorder in Young People.

Authors:  Andrew M Chanen; Katie Nicol; Jennifer K Betts; Katherine N Thompson
Journal:  Curr Psychiatry Rep       Date:  2020-04-25       Impact factor: 5.285

Review 3.  Hallucinations and Other Psychotic Symptoms in Patients with Borderline Personality Disorder.

Authors:  Kamila Belohradova Minarikova; Jan Prasko; Michaela Holubova; Jakub Vanek; Krystof Kantor; Milos Slepecky; Klara Latalova; Marie Ociskova
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-08       Impact factor: 2.570

4.  Psychological therapies for people with borderline personality disorder.

Authors:  Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen
Journal:  Cochrane Database Syst Rev       Date:  2020-05-04

Review 5.  A Life Span Perspective on Borderline Personality Disorder.

Authors:  Arjan C Videler; Joost Hutsebaut; Julie E M Schulkens; Sjacko Sobczak; Sebastiaan P J van Alphen
Journal:  Curr Psychiatry Rep       Date:  2019-06-04       Impact factor: 5.285

6.  Pluripotential Risk and Clinical Staging: Theoretical Considerations and Preliminary Data From a Transdiagnostic Risk Identification Approach.

Authors:  Jessica A Hartmann; Patrick D McGorry; Louise Destree; G Paul Amminger; Andrew M Chanen; Christopher G Davey; Rachid Ghieh; Andrea Polari; Aswin Ratheesh; Hok Pan Yuen; Barnaby Nelson
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

7.  Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.

Authors:  Louise Penzenstadler; Stéphane Kolly; Stéphane Rothen; Yasser Khazaal; Ueli Kramer
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-02-26

8.  A whole of school intervention for personality disorder and self-harm in youth: a pilot study of changes in teachers' attitudes, knowledge and skills.

Authors:  Michelle L Townsend; Annaleise S Gray; Tanya M Lancaster; Brin F S Grenyer
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2018-10-02

9.  Mechanisms of change in brief treatments for borderline personality disorder: a protocol of a randomized controlled trial.

Authors:  Ueli Kramer; Loris Grandjean; Hélène Beuchat; Stéphane Kolly; Philippe Conus; Yves de Roten; Bogdan Draganski; Jean-Nicolas Despland
Journal:  Trials       Date:  2020-04-16       Impact factor: 2.279

Review 10.  Designing a range of mentalizing interventions for young people using a clinical staging approach to borderline pathology.

Authors:  Joost Hutsebaut; Martin Debbané; Carla Sharp
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.